ASP8951, PACLITAXEL, GEMCITABINE
8951-CL-5201
Phase 2 small_molecule active
Quick answer
ASP8951, PACLITAXEL, GEMCITABINE for First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma. is a Phase 2 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active